STRATA SKIN SCIENCES INC (SSKN) is a publicly traded Healthcare sector company. As of May 21, 2026, SSKN trades at $0.19 with a market cap of $0 and a P/E ratio of -0.07. SSKN moved -33.36% today. Year to date, SSKN is -79.37%; over the trailing twelve months it is -90.52%. Its 52-week range spans $0.12 to $3.86. Rallies surfaces SSKN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading SSKN stock inside the company?
Recent SSKN insider activity includes Rubinstein Samuel bought 2.17K, Rubinstein Samuel bought 2.83K, Rubinstein Samuel sold 5.50K, Rubinstein Samuel sold 7.20K, and Rubinstein Samuel sold 1.39K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
SSKN Key Metrics
Key financial metrics for SSKN
Metric
Value
Price
$0.19
Market Cap
$0
P/E Ratio
-0.07
EPS
$-2.63
Dividend Yield
0.00%
52-Week High
$3.86
52-Week Low
$0.12
Volume
4.05M
Avg Volume
0
Revenue (TTM)
$30.98M
Net Income
$-10.87M
Gross Margin
57.74%
Recent SSKN Insider Trades
Rubinstein Samuel bought 2.17K (~$3.04K) on Nov 18, 2025.
Rubinstein Samuel bought 2.83K (~$3.99K) on Nov 18, 2025.
Rubinstein Samuel sold 5.50K (~$7.26K) on Nov 17, 2025.
Rubinstein Samuel sold 7.20K (~$9.65K) on Nov 17, 2025.
Rubinstein Samuel sold 1.39K (~$1.90K) on Nov 17, 2025.
SSKN analyst coverage data. Average price target: $0.00.
Common questions about SSKN
Who is trading SSKN stock inside the company?
Recent SSKN insider activity includes Rubinstein Samuel bought 2.17K, Rubinstein Samuel bought 2.83K, Rubinstein Samuel sold 5.50K, Rubinstein Samuel sold 7.20K, and Rubinstein Samuel sold 1.39K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for SSKN?
Yes. Rallies tracks SSKN insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is SSKN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SSKN. It does not provide personalized investment advice.
